Intuitive Surgical, Inc. Announced Q1 2026 Earnings on April 21, 2026, Reporting "Quarter 1 revenue increased 23% to $2.77 billion"

Intuitive Surgical, Inc. reported that "Quarter 1 revenue increased 23% to $2.77 billion", with "recurring revenue also higher by 23% to $2.4 billion". The company noted "Non-GAAP net income for the first quarter was $901 million" and "Non-GAAP earnings per share was $2.50 per share". Additionally, "Non-GAAP operating margin was strong at 39%" and "Quarter 1 systems revenue grew 24% to $651 million".During the quarter, "total procedures grew 17%, reflecting 16% growth in da Vinci procedures and 39% growth in Ion procedures". The company "placed 431 da Vinci systems in Q1, including 232 da Vinci 5 systems, 34 SP systems" and "placed 52 Ion systems in the quarter". Management stated their priorities include "the global expansion of our platforms, digital feature releases and ecosystem enhancements" and "increased adoption for focused procedures by country".For forward guidance, the company is "increasing our forecast and now expect full year da Vinci procedure growth within a range of 13.5% to 15.5%". They updated their estimate for "non-GAAP gross profit margin to be within a range of 67.5% and 68.5% of revenue". The company also noted they "now expect non-GAAP operating expense growth to be between 11% and 14%".In product updates, the company received "FDA 510(k) clearance for additional uses of our force feedback instruments" and "moved our single port stapler into broad launch". The company also announced that "Dr. Myriam Curet is retiring this quarter after more than 20 years as Intuitive's Chief Medical Officer" and announced "Dr. Jamie Wong's promotion to Chief Medical Officer".